Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer.
暂无分享,去创建一个
Christoph Plass | C. Plass | C. Morrison | D. Smiraglia | G. Otterson | Laura T. Smith | D. Schuller | R. M. Brena | J. Lang | Gregory A Otterson | Carl D Morrison | Laura T Smith | Romulo M Brena | Dominic J Smiraglia | James C Lang | David E Schuller | Mauting Lin | Mauting Lin
[1] K Autio,et al. DNA copy number losses in human neoplasms. , 1999, The American journal of pathology.
[2] Chun Xing Li,et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3 , 2000, Nature Genetics.
[3] E. Speel,et al. Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors. , 2001, The American journal of pathology.
[4] C. Rinker-Schaeffer,et al. Metastasis-suppressor genes: a review and perspective on an emerging field. , 2000, Journal of the National Cancer Institute.
[5] J. Rossant,et al. The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. , 1999, Development.
[6] I. Petersen,et al. Genomic alterations associated with malignancy in head and neck cancer , 1998, Head & neck.
[7] A. Berns,et al. Mouse models for human lung cancer. , 2005, Genes & development.
[8] E. Olson,et al. Control of Facial Muscle Development by MyoR and Capsulin , 2002, Science.
[9] M. Takagi,et al. Frequent promoter hypermethylation of RASSF1A and p16INK4a and infrequent allelic loss other than 9p21 in betel-associated oral carcinoma in a Vietnamese non-smoking/non-drinking female population. , 2005, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[10] J. Mark,et al. Partial 6q deletion in a human salivary gland adenocarcinoma. , 1989, Cancer genetics and cytogenetics.
[11] G. Prindull,et al. Environmental guidance of normal and tumor cell plasticity: epithelial mesenchymal transitions as a paradigm. , 2004, Blood.
[12] T. Jacks,et al. Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer , 2005, Cell.
[13] E. Olson,et al. The basic helix-loop-helix transcription factor capsulin controls spleen organogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[14] N. Perrimon,et al. Apicobasal polarization: epithelial form and function. , 2003, Current opinion in cell biology.
[15] A. Knudson,et al. Two genetic hits (more or less) to cancer , 2001, Nature Reviews Cancer.
[16] M. Takata,et al. Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23. , 2001, Cancer research.
[17] J. Minna,et al. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[18] E. Olson,et al. Capsulin: a novel bHLH transcription factor expressed in epicardial progenitors and mesenchyme of visceral organs , 1998, Mechanisms of Development.
[19] C. Plass,et al. Bone morphogenetic protein 3B silencing in non-small-cell lung cancer , 2004, Oncogene.
[20] J. Herman,et al. Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.
[21] A. Kiemer,et al. Identification of genes involved in epithelial-mesenchymal transition and tumor progression , 2001, Oncogene.
[22] Peter A. Jones,et al. The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.
[23] Colin C. Collins,et al. Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors , 2002, Nature Genetics.
[24] K. Chada,et al. Expression of Mesenchyme-Specific Gene HMGA2 in Squamous Cell Carcinomas of the Oral Cavity , 2004, Cancer Research.
[25] J. Shannon,et al. Epithelial-mesenchymal interactions in the developing lung. , 2004, Annual review of physiology.
[26] J. Mark,et al. 6q- and loss of the Y chromosome--two common deviations in malignant human salivary gland tumors. , 1986, Cancer genetics and cytogenetics.
[27] J. Herman,et al. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. , 2001, Human molecular genetics.
[28] Marshall W. Anderson,et al. A major lung cancer susceptibility locus maps to chromosome 6q23-25. , 2004, American journal of human genetics.
[29] C. Morelli,et al. A human melanoma metastasis‐suppressor locus maps to 6q16.3‐q23 , 2000, International journal of cancer.
[30] P. Friedl,et al. Tumour-cell invasion and migration: diversity and escape mechanisms , 2003, Nature Reviews Cancer.
[31] A. Bukovsky,et al. Association of mesenchymal cells and immunoglobulins with differentiating epithelial cells , 2001, BMC Developmental Biology.
[32] R. Happonen,et al. Specificity of 6q- markers and other recurrent deviations in human malignant salivary gland tumors. , 1988, Anticancer research.
[33] C. Rinker-Schaeffer,et al. What defines a useful marker of metastasis in human cancer? , 1999, Journal of the National Cancer Institute.
[34] J. Minna,et al. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. , 2000, Cancer research.
[35] K. Parker,et al. Disrupted gonadogenesis and male-to-female sex reversal in Pod1 knockout mice , 2004, Development.
[36] Y. Hayashizaki,et al. An expanded system of restriction landmark genomic scanning (RLGS Ver. 1.8) , 1995, Electrophoresis.
[37] J. Thiery. Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.
[38] B. Boyer,et al. Induction and regulation of epithelial-mesenchymal transitions. , 2000, Biochemical pharmacology.
[39] M. Caligiuri,et al. Aberrant CpG-island methylation has non-random and tumour-type–specific patterns , 2000, Nature Genetics.
[40] G. Pfeifer,et al. Methylation of the RASSF1A Gene in Human Cancers , 2002, Biological chemistry.
[41] C. R. Leemans,et al. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. , 2004, Journal of the National Cancer Institute.
[42] I. Tomlinson,et al. Loss of heterozygosity analysis: Practically and conceptually flawed? , 2002, Genes, chromosomes & cancer.
[43] Masataka Nakamura,et al. Basic Helix-Loop-Helix Transcription Factor Epicardin/Capsulin/Pod-1 Suppresses Differentiation by Negative Regulation of Transcription* , 2003, The Journal of Biological Chemistry.
[44] B. Weissman,et al. Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. , 1994, Oncogene.